Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,837 papers from all fields of science
Search
Sign In
Create Free Account
Acute Myeloid Leukemia with Mutated NPM1
Known as:
AML with Mutated NPM1
, Acute Myeloid Leukemia with Cytoplasmic Nucleophosmin
, NPMc+ AML
An acute myeloid leukemia with mutation of the nucleophosmin gene. It is usually associated with normal karyotype and frequently has myelomonocytic…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Bone Marrow
Bone marrow stem cell
Gene Abnormality
Hematopoietic and Lymphoid Cell
Expand
Broader (1)
Leukemia, Myelocytic, Acute
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
PF228 DIAGNOSTIC VALUE OF PU.1 LOCALIZATION IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1
G. Pianigiani
,
C. Betti
,
R. Rossi
,
B. Bigerna
,
L. Brunetti
HemaSphere
2019
Corpus ID: 196537929
2019
2019
PS995 IMPACT OF DNMT3A MUTATIONAL STATUS IN MOLECULAR MEASURABLE RESIDUAL DISEASE CLEARANCE IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1
G. Oñate
,
A. Bataller
,
+12 authors
M. Pratcorona
HemaSphere
2019
Corpus ID: 196559178
Review
2019
Review
2019
The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know.
D. Arber
Seminars in hematology (Print)
2019
Corpus ID: 56675004
In 2016 a revision of the World Health Organization (WHO) classification of acute myeloid leukemia (AML) was introduced that…
Expand
2018
2018
Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1
Yi Zhou
,
Andres Moon
,
+6 authors
David Wu
Cytometry. Part B, Clinical cytometry
2018
Corpus ID: 53285193
The presence of measurable residual disease after therapy is a significant risk factor of relapse in patients with acute myeloid…
Expand
Highly Cited
2013
Highly Cited
2013
Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.
R. Walter
,
M. Othus
,
+10 authors
E. Estey
Blood
2013
Corpus ID: 206916306
The World Health Organization (WHO) classifies acute myeloid leukemia (AML) via genetic, immunophenotypic, biological, and…
Expand
Review
2010
Review
2010
New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues.
B. Falini
,
E. Tiacci
,
M. Martelli
,
S. Ascani
,
S. Pileri
Discover medicine
2010
Corpus ID: 20543064
The World Health Organization (WHO) classification of lympho-hematopoietic neoplasms is increasingly based on genetic criteria…
Expand
2010
2010
Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
B. Falini
Cancer treatment and research
2010
Corpus ID: 27443641
The NPM1 gene encodes for nucleophosmin, a nucleolus-located shuttling protein that is involved in multiple cell functions…
Expand
2009
2009
Acute Myeloid Leukemia with Mutated NPM1 Presenting with Life-Threatening, Either Arterial or Venous, Thromboembolism: a Report of 4 Cases.
M. Martelli
,
L. Brunetti
,
+11 authors
B. Falini
2009
Corpus ID: 57786340
Abstract 4135 Acute myeloid leukemia (AML) expressing mutated NPM1 gene and cytoplasmic nucleophosmin (NPMc+ AML) [Falini B et al…
Expand
Review
2009
Review
2009
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
B. Falini
,
P. Sportoletti
,
M. Martelli
Current Opinion in Oncology
2009
Corpus ID: 12417427
Purpose of review Nucleophosmin (NPM1) gene mutations, which cause aberrant cytoplasmic expression of nucleophosmin (NPMc+), are…
Expand
Highly Cited
2009
Highly Cited
2009
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.
C. Haferlach
,
C. Mecucci
,
+11 authors
B. Falini
Blood
2009
Corpus ID: 14076050
Acute myeloid leukemia (AML) with mutated NPM1 usually carries normal karyotype (NK), but it may harbor chromosomal aberrations…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required